TOP HEADLINES

Featured Story

  • Heart experts link biomarkers with high risk of 'silent strokes'

    An investigative team of heart experts has tracked down a pair of biomarkers they say can flag people who are at risk of having "silent strokes," asymptomatic events that can quietly damage the brain and leave them threatened by even worse incidents of heart and vascular disease.

HPV antibodies point researchers to high risk for oral cancer

With rates of oral cancer linked to HPV infection on the rise, a group of investigators has pinned down a new biomarker that can be used to identify high-risk patients.

Brain scan may provide biomarker guideposts to ideal depression treatment

Activity in certain parts of the brain appears to offer solid biomarker guideposts to whether drugs or psychotherapy works best to treat depression, researchers have found. And a pretreatment brain scan helps make the determination.

Biomarker aids in gestational diabetes risk prediction

Measurement of particular blood biomarker during a pregnant women's first trimester may be a good way to help predict how likely it is she'll face gestational diabetes, Japanese researchers have found.

Gene points way to noninvasive colon cancer blood test

Early detection boosts colon cancer survival rates. The Yonsei University College of Medicine in Seoul, South Korea, and Genomictree believe they can accomplish this goal, thanks to a noninvasive biomarker blood test that appears to be highly accurate based on initial clinical work.

Genetic biomarker could help scientists select cell lines for stem cell studies

Researchers at Boston Children's Hospital have identified a biomarker that could help match the right stem cell line to patients to more effectively treat a variety of cancers.

MORE NEWS

From Our Sister Sites

FiercePharma Manufacturing

Gilead Sciences has recalled 20 batches of its antifungal drug AmBisome after bacterial contamination was discovered during a routine test at its plant in San Dimas, CA.

FierceDrugDelivery

Researchers in the U.S., the U.K. and Australia have developed a biosensor nanotechnology that could improve drug delivery for the treatment of pancreatic cancer while allowing for imaging at the same time, according to a report inĀ  Asian Scientist .